Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
We identified an autosomal recessive infantile-onset symptomatic epilepsy syndrome associated with developmental stagnation and blindness. Assuming a founder effect in a large Old Order Amish pedigree, we carried out a genome-wide screen for linkage and identified a single region of homozygosity on chromosome 2p12-p11.2 spanning 5.1 cM (maximum lod score of 6.84). We sequenced genes in the region and identified a nonsense mutation in SIAT9, which is predicted to result in the premature termination of the GM3 synthase enzyme (also called lactosylceramide alpha-2,3 sialyltransferase). GM3 synthase is a member of the sialyltransferase family and catalyzes the initial step in the biosynthesis of most complex gangliosides from lactosylceramide. Biochemical analysis of plasma glycosphingolipids confirmed that affected individuals lack GM3 synthase activity, as marked by a complete lack of GM3 ganglioside and its biosynthetic derivatives and an increase in lactosylceramide and its alternative derivatives. Although the relationship between defects in ganglioside catabolism and a range of lysosomal storage diseases is well documented, this is the first report, to our knowledge, of a disruption of ganglioside biosynthesis associated with human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Munro, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00882-1 · Cited by 1,514
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Mice Expressing Only Monosialoganglioside GM3 Exhibit Lethal Audiogenic Seizures
Kawai, H., Allende, M. L., Wada, R., Kono, M., Sango, K., Deng, C., Miyakawa, T., Crawley, J. N., Werth, N., Bierfreund, U., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000847200 · Cited by 227
Gangliosides as modulators of cell function
Zeller, C. B., & Marchase, R. B. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.6.c1341 · Cited by 208
Biosynthesis and degradation of mammalian glycosphingolipids
Sandhoff, K., & Kolter, T. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1265 · Cited by 183
Neville, D. C. A., Coquard, V., Priestman, D. A., te Vruchte, D. J. M., Sillence, D. J., Dwek, R. A., Platt, F. M., & Butters, T. D. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.051 · Cited by 178
Self-citationTraveling for the glycosphingolipid path
Hakomori, S.-I. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011086929064 · Cited by 178
Wraith, J. E. (2002) · Seminars in Neonatology · doi:10.1053/siny.2001.0088 · Cited by 166
Refractory Skin Injury in Complex Knock-out Mice Expressing Only the GM3 Ganglioside
Inoue, M., Fujii, Y., Furukawa, K., Okada, M., Okumura, K., Hayakawa, T., Furukawa, K., & Sugiura, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201631200 · Cited by 107
Glycosphingolipid functions: insights from engineered mouse models
Proia, R. L. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1268 · Cited by 84
Cited by
Items 101–200 of 389
Baycin‐Hizal, D., Gottschalk, A., Jacobson, E. F., Mai, S., Wolozny, D., Zhang, H., Krag, S. S., & Betenbaugh, M. J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.067 · Cited by 64
Ganglioside Regulation of AMPA Receptor Trafficking
Prendergast, J. M., Umanah, G. K. E., Yoo, S.-W., Lagerlöf, O., Motari, M. G., Cole, R. N., Huganir, R. L., Dawson, T. M., Dawson, V. L., & Schnaar, R. L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1149-14.2014 · Cited by 65
Ng, B. G., & Freeze, H. H. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9752-1 · Cited by 68
Allende, M. L., & Proia, R. L. (2014) · Glycoconjugate Journal · doi:10.1007/s10719-014-9563-5 · Cited by 64
CLN 5 and CLN 8 protein association with ceramide synthase: Biochemical and proteomic approaches
Haddad, S. E., Khoury, M., Daoud, M., Kantar, R., Harati, H., Mousallem, T., Alzate, O., Meyer, B., & Boustany, R. (2012) · ELECTROPHORESIS · doi:10.1002/elps.201200472 · Cited by 60
Dukhinova, M., Kuznetsova, I. S., Kopeikina, E., Veniaminova, E. A., Yung, A. W. Y., Veremeyko, T., Levchuk, K., Barteneva, N. S., Wing-Ho, K. K., Yung, W., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.009 · Cited by 66
Metabolic and cellular bases of sphingolipidoses
Sandhoff, K. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130083 · Cited by 60
Lyso-glycosphingolipids: presence and consequences
van Eijk, M., Ferraz, M. J., Boot, R. G., & Aerts, J. M. F. G. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190090 · Cited by 68
Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells
Yoshikawa, M., Go, S., Suzuki, S.-I., Suzuki, A., Katori, Y., Morlet, T., Gottlieb, S. M., Fujiwara, M., Iwasaki, K., Strauss, K. A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv041 · Cited by 58
miRNA proxy approach reveals hidden functions of glycosylation
Kurćon, T., Liu, Z., Paradkar, A. V., Vaiana, C. A., Koppolu, S., Agrawal, P. K., & Mahal, L. K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502076112 · Cited by 65
Reduced ceramide synthase 2 activity causes progressive myoclonic epilepsy
Mosbech, M., Olsen, A. S. B., Neess, D., Ben‐David, O., Klitten, L. L., Larsen, J., Sabers, A., Vissing, J., Nielsen, J. E., Hasholt, L., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.28 · Cited by 63
Rymen, D., & Jaeken, J. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9678-7 · Cited by 56
Lee, J. S., Yoo, Y., Lim, B. C., Kim, K. J., Song, J., Choi, M., & Chae, J. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37773 · Cited by 57
Recessive GM3 synthase deficiency: Natural history, biochemistry, and therapeutic frontier
Bowser, L. E., Young, M., Wenger, O. K., Ammous, Z., Brigatti, K. W., Carson, V. J., Moser, T., Deline, J., Aoki, K., Morlet, T. G., et al. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.01.013 · Cited by 59
Reduced sialylation triggers homeostatic synapse and neuronal loss in middle-aged mice
Klaus, C., Hansen, J. N., Ginolhac, A., Gérard, D., Gnanapragassam, V. S., Horstkorte, R., Rossdam, C., Buettner, F. F. R., Sauter, T., Sinkkonen, L., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.01.008 · Cited by 54
Metabolic pathways and intracellular trafficking of gangliosides
Daniotti, J. L., & Iglesias‐Bartolomé, R. (2011) · IUBMB Life · doi:10.1002/iub.477 · Cited by 66
Yanagisawa, M. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0358-1 · Cited by 55
Lipid profiling of parkin‐mutant human skin fibroblasts
Lobasso, S., Tanzarella, P., Vergara, D., Maffia, M., Cocco, T., & Corcelli, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25815 · Cited by 60
Condon, K. H., Ho, J., Robinson, C. G., Hanus, C., & Ehlers, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1930-11.2013 · Cited by 63
Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency
Wang, H., Bright, A., Xin, B., Bockoven, J. R., & Paller, A. S. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35826 · Cited by 51
Self-citationGarcía‐Cazorla, À., Mochel, F., Lamari, F., & Saudubray, J. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9776-6 · Cited by 52
Mochel, F. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0204-1 · Cited by 22
Daniotti, J. L., Lardone, R. D., & Vilcaes, A. A. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2015.00300 · Cited by 57
Huang, Q., Zhou, X., Liu, D., Xin, B., Cechner, K., Wang, H., & Zhou, A. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.03.014 · Cited by 48
Self-citationYao, D., McGonigal, R., Barrie, J. A., Cappell, J., Cunningham, M. E., Meehan, G. R., Fewou, S. N., Edgar, J. M., Rowan, E., Ohmi, Y., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3996-13.2014 · Cited by 48
Exogenous gangliosides increase the release of brain-derived neurotrophic factor
Seung Taik, L. I. M., Esfahani, K., Avdoshina, V., & Mocchetti, I. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.012 · Cited by 54
The way we view cellular (glyco)sphingolipids
Hoetzl, S., Sprong, H., & Gerrit van, M. E. E. R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04721.x · Cited by 53
Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment
Àvila, I. V. D. H., Windhouwer, B., & van Vliet, S. J. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10108-z · Cited by 51
Insights into complexity of congenital disorders of glycosylation
Goreta, S. Š., Dabelić, S., & Dumić, J. (2012) · Biochemia Medica · doi:10.11613/bm.2012.019 · Cited by 59
Genetic diseases of sphingolipid metabolism: Pathological mechanisms and therapeutic options
Kacher, Y., & Futerman, A. H. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.041 · Cited by 53
Chen, Y., Pedersen, J. W., Wandall, H. H., Levery, S. B., Pizette, S., Clausen, H., & Cohen, S. M. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.04.013 · Cited by 51
Novel B4GALNT1 mutations in a complicated form of hereditary spastic paraplegia
Wakil, S. M., Monies, D., Ramzan, K., Hagos, S., Bastaki, L. A., Meyer, B. F., & Bohlega, S. (2013) · Clinical Genetics · doi:10.1111/cge.12312 · Cited by 45
Gangliosides in Nerve Cell Specification
Itokazu, Y., Wang, J., & Yu, R. K. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.12.008 · Cited by 48
Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation
Trinchera, M., Parini, R., Indellicato, R., Domenighini, R., & Dall’Olio, F. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.06.014 · Cited by 47
Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
Wallom, K., Fernández‐Suárez, M. E., Priestman, D. A., Vruchte, D. T., Huebecker, M., Hallett, P. J., Isacson, O., & Platt, F. M. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-10023-x · Cited by 47
Self-citationTumor gangliosides accelerate murine tumor angiogenesis
Liu, Y., Wondimu, A., Yan, S., Bobb, D., & Ladisch, S. (2013) · Angiogenesis · doi:10.1007/s10456-013-9403-4 · Cited by 44
Kurzawa‐Akanbi, M., Whitfield, P. D., Burté, F., Bertelli, P. M., Pathak, V., Doherty, M. K., Hilgen, B., Gliaudelytė, L., Platt, M., Queen, R. A., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12295 · Cited by 44
The α2B‐adrenergic receptor is mutant in cortical myoclonus and epilepsy
Fusco, M. D., Vago, R., Striano, P., Bonaventura, C. D., Zara, F., Mei, D., Kim, M. S., Muallem, S., Chen, Y., Wang, Q., et al. (2013) · Annals of Neurology · doi:10.1002/ana.24028 · Cited by 43
Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts
Liu, Y., Su, Y., Wiznitzer, M., Epifano, O., & Ladisch, S. (2008) · Glycobiology · doi:10.1093/glycob/cwn039 · Cited by 48
Self-citationItokazu, Y., Fuchigami, T., Morgan, J. C., & Yu, R. K. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.005 · Cited by 45
Roles of gangliosides in mouse embryogenesis and embryonic stem cell differentiation
Kwak, D. H., Seo, B. B., Chang, K. T., & Choo, Y. K. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.7.048 · Cited by 43
HFE gene variants, iron, and lipids: a novel connection in Alzheimer’s disease
Ali-Rahmani, F., Schengrund, C.-L., & Connor, J. R. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00165 · Cited by 42
Membrane glycolipids in stem cells
Yu, R. K., Suzuki, Y., & Yanagisawa, M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.08.026 · Cited by 51
Moskot, M., Bocheńska, K., Jakóbkiewicz‐Banecka, J., Banecki, B., & Gabig‐Cimińska, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010247 · Cited by 43
Bhuiyan, R. H., Ohmi, Y., Ohkawa, Y., Zhang, P., Takano, M., Hashimoto, N., Okajima, T., Furukawa, K., & Furukawa, K. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.11.034 · Cited by 43
Gangliosides help stabilize the brain
Proia, R. L. (2004) · Nature Genetics · doi:10.1038/ng1104-1147 · Cited by 47
Lipid rafts and human diseases: why we need to target gangliosides
Fantini, J. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13612 · Cited by 43
Indellicato, R., Parini, R., Domenighini, R., Malagolini, N., Iascone, M. R., Gasperini, S., Masera, N., Dall’Olio, F., & Trinchera, M. (2018) · Glycobiology · doi:10.1093/glycob/cwy112 · Cited by 41
Pérez‐Cerdá, C., Quelhas, D., Vega, A. I., Ecay, M. J., Vilarinho, L., & Ugarte, M. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.093450 · Cited by 38
Associations of genetic polymorphisms of Siglecs with human diseases
Angata, T. (2014) · Glycobiology · doi:10.1093/glycob/cwu043 · Cited by 38
Etiology of Vision Loss in Ganglioside GM3 Synthase Deficiency
Farukhi, F., Dakkouri, C., Wang, H., Wiztnitzer, M., & Traboulsi, E. I. (2006) · Ophthalmic Genetics · doi:10.1080/13816810600862626 · Cited by 37
Self-citationIndellicato, R., & Trinchera, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133304 · Cited by 38
Congenital Disorders of Ganglioside Biosynthesis
Li, T. A., & Schnaar, R. L. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.01.001 · Cited by 43
Secondary Alterations of Sphingolipid Metabolism in Lysosomal Storage Diseases
Prinetti, A., Prioni, S., Chiricozzi, E., Schuchman, E. H., Chigorno, V., & Sonnino, S. (2011) · Neurochemical Research · doi:10.1007/s11064-010-0380-3 · Cited by 42
Dendritic trafficking for neuronal growth and plasticity
Ehlers, M. D. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130081 · Cited by 36
Human genetic disorders of sphingolipid biosynthesis
Astudillo, L. M., Sabourdy, F., Therville, N., Bode, H., Ségui, B., Andrieu‐Abadie, N., Hornemann, T., & Levade, T. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9736-1 · Cited by 42
Gangliosides and Neuroblastomas
Schengrund, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155313 · Cited by 35
Liu, Y., Yan, S., Wondimu, A., Bob, D., Weiss, M., Sliwinski, K., Villar, J., Notario, V., Sutherland, M. L., Colberg‐Poley, A. M., et al. (2010) · Oncogene · doi:10.1038/onc.2010.85 · Cited by 35
Sibille, E., Berdeaux, O., Martine, L., Bron, A. M., Creuzot-Garcher, C. P., Hé, Z., Thuret, G., Brétillon, L., & Masson, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168794 · Cited by 33
Ohmi, Y., Ohkawa, Y., Tajima, O., Sugiura, Y., Furukawa, K., & Furukawa, K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-61 · Cited by 35
Kurz, E., Chen, S., Vucic, E., Baptiste, G. G., Loomis, C. A., Agrawal, P. K., Hajdu, C. H., Bar‐Sagi, D., & Mahal, L. K. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100160 · Cited by 33
Iglesias‐Bartolomé, R., Trenchi, A., Comín, R., Moyano, A. L., Nores, G. A., & Daniotti, J. L. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.09.018 · Cited by 36
Metabolic and monogenic causes of seizures in neonates and young infants
Hove, J. L. K. V., & Lohr, N. J. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.04.020 · Cited by 36
Functional Diversity of Mammalian Sialyltransferases
Takashima, S., & Tsuji, S. (2011) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.23.178 · Cited by 36
Glycosphingolipids in the Regulation of the Nervous System
Furukawa, K., Ohmi, Y., Ohkawa, Y., Tajima, O., & Furukawa, K. (2014) · Advances in neurobiology · doi:10.1007/978-1-4939-1154-7_14 · Cited by 37
Mu, H. H., Wang, X., Wang, H., Lin, P. H., Yao, Q. C., & Chen, C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01254.2008 · Cited by 31
Self-citationGanglioside Metabolism and Its Inherited Diseases
Breiden, B., & Sandhoff, K. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8552-4_5 · Cited by 37
Regulatory function of glycosphingolipids in the inflammation and degeneration
Furukawa, K., Ohmi, Y., Kondo, Y., Ohkawa, Y., Tajima, O., & Furukawa, K. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.02.007 · Cited by 33
Congenital disorders of glycosylation and intellectual disability
Wolfe, L. A., & Krasnewich, D. M. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1115 · Cited by 31
Glycosphingolipide – Natur, Funktion und pharmakologische Modulierung
Wennekes, T., van den Berg, R. J. B. H. N., Boot, R. G., van der Marel, G. A., Overkleeft, H. S., & Aerts, J. M. F. G. (2009) · Angewandte Chemie · doi:10.1002/ange.200902620 · Cited by 30
Ma, X., Liu, G., Wang, S., Chen, Z., Lai, M., Liu, Z., & Yang, J. J. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.09.027 · Cited by 32
Early growth and development impairments in patients with ganglioside GM3 synthase deficiency
Wang, H., Wang, A., Wang, D., Bright, A., Sency, V., Zhou, A., & Xin, B. (2015) · Clinical Genetics · doi:10.1111/cge.12703 · Cited by 29
Self-citationA Proposed Diagnostic Algorithm for Inborn Errors of Metabolism Presenting With Movements Disorders
Ortigoza‐Escobar, J. D. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.582160 · Cited by 31
Dodge, J. C., Tamsett, T. J., Treleaven, C. M., Taksir, T. V., Piepenhagen, P. A., Sardi, S. P., Cheng, S. H., & Shihabuddin, L. S. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00966-0 · Cited by 27
Monogenic neurological disorders of sphingolipid metabolism
Sabourdy, F., Astudillo, L. M., Colacios, C., Dubot, P., Mrad, M., Ségui, B., Andrieu‐Abadie, N., & Levade, T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.01.010 · Cited by 39
Wen-wen, S., Ma, C., Wang, S., Xiong, H., Lu, H., & Yang, P. (2010) · Chemistry - An Asian Journal · doi:10.1002/asia.200900542 · Cited by 28
Glycolipids: Essential regulator of neuro-inflammation, metabolism and gliomagenesis
Furukawa, K., Ohmi, Y., Ji, S., Zhang, P., Bhuiyan, R. H., Ohkawa, Y., Tajima, O., Hashimoto, N., & Furukawa, K. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.06.007 · Cited by 27
Gordon‐Lipkin, E. M., Cohen, J. S., Srivastava, S., Soares, B. P., Levey, E. B., & Fatemi, A. S. (2018) · Journal of Child Neurology · doi:10.1177/0883073818791099 · Cited by 28
Miyagi, T., & Yamaguchi, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00055-6 · Cited by 44
Glycosphingolipid Disorders of the Brain
Boomkamp, S. D., & Butters, T. D. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_17 · Cited by 30
Self-citationImplications for the mammalian sialidases in the physiopathology of skeletal muscle
Fanzani, A., Zanola, A., Faggi, F., Papini, N., Venerando, B., Tettamanti, G., Sampaolesi, M., & Monti, E. (2012) · Skeletal Muscle · doi:10.1186/2044-5040-2-23 · Cited by 32
Sphingolipids and impaired hypoxic stress responses in Huntington disease
Burtscher, J., Pepe, G., Maharjan, N., Riguet, N., Pardo, A. D., Maglione, V., & Millet, G. P. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101224 · Cited by 28
Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene
Xia, T., Zeng, G., Gao, L., & Yu, R. K. (2005) · Gene · doi:10.1016/j.gene.2005.03.010 · Cited by 26
Apprehending ganglioside diversity: a comprehensive methodological approach
Masson, E., Sibille, E., Martine, L., Chaux, F., Brétillon, L., & Berdeaux, O. (2015) · Journal of Lipid Research · doi:10.1194/jlr.d060764 · Cited by 31
Neuromuscular synaptic function in mice lacking major subsets of gangliosides
Zitman, F. M. P., Todorov, B., Jacobs, B. C., Verschuuren, J. J. G. M., Furukawa, K., Furukawa, K., Willison, H. J., & Plomp, J. J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.034 · Cited by 25
Sphingolipids controlling ciliary and microvillar function
Kaiser, F., Huebecker, M., & Wachten, D. (2020) · FEBS Letters · doi:10.1002/1873-3468.13816 · Cited by 26
GM3 synthase deficiency in non-Amish patients
Heide, S., Jacquemont, M., Cheillan, D., Renouil, M., Tallot, M., Schwartz, C. E., Miquel, J., Bintner, M., Rodriguez, D., Darcel, F., et al. (2021) · Genetics in Medicine · doi:10.1016/j.gim.2021.10.007 · Cited by 25
Transfer of gangliosides across the human placenta
Mitchell, M. D., Henare, K. L., Balakrishnan, B., Lowe, E. K., Fong, B., & McJarrow, P. (2012) · Placenta · doi:10.1016/j.placenta.2011.12.018 · Cited by 28
van Diepen, L., Buettner, F. F. R., Hoffmann, D., Thiesler, C. T., Halbach, O. V. B. U., Halbach, V. V. B. U., Jensen, L. R., Steinemann, D., Edvardson, S., Elpeleg, O. N., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0220-5 · Cited by 24
NANS-CDG: Delineation of the Genetic, Biochemical, and Clinical Spectrum
den Hollander, B., Rasing, A., Post, M. A., Klein, W. M., Oud, M. M., Brands, M. M. M. G., de Boer, L., Engelke, U. F. H., van Essen, P., Fuchs, S. A., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.668640 · Cited by 25
Membrane Raft Disruption Promotes Axonogenesis in N2a Neuroblastoma Cells
Petro, K. A., & Schengrund, C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9625-9 · Cited by 24
Huang, Q., Liu, D., Xin, B., Cechner, K., Zhou, X., Wang, H., & Zhou, A. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.04.043 · Cited by 23
Self-citationWang, W. X., & Whitehead, S. N. (2020) · The Analyst · doi:10.1039/c9an02270h · Cited by 23
Novel Molecular Mechanisms of Gangliosides in the Nervous System Elucidated by Genetic Engineering
Furukawa, K., Ohmi, Y., Yesmin, F., Tajima, O., Kondo, Y., Zhang, P., Hashimoto, N., Ohkawa, Y., Bhuiyan, R. H., & Furukawa, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061906 · Cited by 24
Sphingolipids regulate neuromuscular synapse structure and function in Drosophila
West, R. J. H., Briggs, L., Fjeldstad, M. P., Ribchester, R. R., & Sweeney, S. T. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24466 · Cited by 23
Lagutin, K., MacKenzie, A., Bloor, S. J., Scott, D., & Vyssotski, M. V. (2022) · Separations · doi:10.3390/separations9060145 · Cited by 23
Dietary Control of Ganglioside Expression in Mammalian Tissues
OKUDA, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010177 · Cited by 22
Gangliosides in the Nervous System: Biosynthesis and Degradation
Yu, R. K., Ariga, T., Yanagisawa, M., & Zeng, G. (2008) · Springer eBooks · doi:10.1007/978-3-540-30429-6_41 · Cited by 21
Hülsmeier, A. J. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106851 · Cited by 27
Paller, A. S., & Mancini, A. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24475-6.00024-8 · Cited by 21
Metadata
- Authors
- Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C. A., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., Pryde, A., Patton, M. A., Dwek, R. A., Butters, T. D., Platt, F. M., & Crosby, A. H.
- Affiliations
- University of London (GB)
- University of Arizona (US)
- University of Oxford (GB)
- Rainbow Babies & Children's Hospital (US)
- Corresponding author
- Crosby, Andrew H
- ORCID
- Venue
- Nature Genetics
- Published
- 2004-10-24
- Volume
- 36
- Issue
- 11
- Pages
- 1225-1229
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2161292836
- Cited by
- 389
- References
- 22
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 17 · 2023: 20 · 2022: 25 · 2021: 18 · 2020: 25 · 2019: 15 · 2018: 29 · 2017: 11 · 2016: 19 · 2015: 16 · 2014: 27 · 2013: 19 · 2012: 18
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Research to Prevent Blindness
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- GM3 synthase, loss-of-function mutations, autosomal recessive inheritance, founder effect, Old Order Amish, ganglioside biosynthesis, GM3 ganglioside, lactosylceramide, glycosphingolipids, blindness, sialyltransferase, linkage mapping
- MeSH terms
- Blindness, Developmental Disabilities, Chromosomes, Human, Pair 2, Epilepsy, Female, G(M3) Ganglioside, Genes, Recessive, Glycosphingolipids, Humans, Infant, Infant, Newborn, Male, Pedigree, Sialyltransferases, Syndrome, Codon, Nonsense, Founder Effect
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.